Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Predictive Oncology Inc (NQ: POAI )

0.6800 +0.0300 (+4.62%)
Streaming Delayed Price Updated: 12:44 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 25,910
Open 0.6800
Bid (Size) 0.6712 (1)
Ask (Size) 0.6900 (6)
Prev. Close 0.6500
Today's Range 0.6565 - 0.6811
52wk Range 0.5500 - 3.760
Shares Outstanding 4,063,081
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
This SolarEdge Technologies Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday
Via Benzinga
Predictive Oncology Reports Third Quarter 2024 Financial Results and Provides Strategic Update
Company initiates process to explore a broad range of strategic alternatives to maximize shareholder value 
From Predictive Oncology Inc.
Via GlobeNewswire

Performance

YTD
-80.71%
-80.71%
1 Month
+2.38%
+2.38%
3 Month
-29.90%
-29.90%
6 Month
-58.28%
-58.28%
1 Year
-77.41%
-77.41%

More News

Read More
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Predictive Oncology to Present at the H.C. Wainwright 26th Annual Global Investment Conference
From Predictive Oncology Inc.
Via GlobeNewswire
POAI Stock Earnings: Predictive Oncology Reported Results for Q2 2024
Via InvestorPlace
Why Is Predictive Oncology (POAI) Stock Up 70% Today?
Via InvestorPlace
TinyGemsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Reports on Study Confirming Long-Term Stability, Viability of Proprietary Tumor Specimen Biobank
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Predictive Oncology Study Demonstrates Long-Term Stability and Viability of Proprietary Biobank of Primary Tumor Specimens for Pharmaceutical Drug Discovery
From Predictive Oncology Inc.
Via GlobeNewswire
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces Q2 2024 Financial Results, Provides Business Update
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Predictive Oncology Reports Second Quarter 2024 Financial Results and Provides Business Update
From Predictive Oncology Inc.
Via GlobeNewswire
BioMedNewsBreaks — Predictive Oncology Inc. (NASDAQ: POAI) Announces Expansion of Live-Cell Tumor Platform Applications
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Predictive Oncology Expands the Application of its Live-Cell Tumor Platform to De-Risk Drug Discovery and Accelerate Pipeline Development
From Predictive Oncology Inc.
Via GlobeNewswire
AINewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Schedules Release of Q2 2024 Financial Results, Conference Call
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Predictive Oncology to Report Second Quarter 2024 Financial Results on Wednesday, August 14, 2024
From Predictive Oncology Inc.
Via GlobeNewswire
Why Saia Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
AINewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Enters into $1.2M Agreement for Exercise of Warrants
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Predictive Oncology Announces Exercise of Warrants for $1.26 Million Gross Proceeds
From Predictive Oncology Inc.
Via GlobeNewswire
Why Edwards Lifesciences Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Why Predicitive Oncology Stock Is Soaring
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Nasdaq Gains 1%; American Airlines Cuts Earnings Forecast
Via Benzinga
Dow Jumps 200 Points; Honeywell Trims Profit Outlook
Via Benzinga
Topics Stocks
Exposures US Equities
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Expands Its AI/ML Driven Platform to Include Novel Oncology Biomarker Discovery
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Predictive Oncology Enters Biomarker Discovery Market After Successful Retrospective Ovarian Cancer Study Yields Compelling Results
From Predictive Oncology Inc.
Via GlobeNewswire
7 F-Rated Growth Stocks to Avoid Right Now: June 2024
Via InvestorPlace
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Unveils Novel Technology, Eyes Significant Partnership Opportunities
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.